Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Wednesday, December 01, 2021
Vaxart, Inc. has entered into an agreement with Kindred Bioscience, Inc. for the purchase of KindredBio’s manufacturing equipment and sublease of its GMP (Good Manufacturing Practices) manufacturing ...
read more
Wednesday, November 24, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.
read more
Monday, November 22, 2021
Pfizer Inc. and BioNTech SE announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.
read more
Friday, November 19, 2021
New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials both showed robust efficacy from a one-time intramuscular (IM) dose of the long-acting antibody (...
read more
Friday, November 19, 2021
Amneal Pharmaceuticals, Inc. has received Abbreviated New Drug Application (ANDA) approval from the U.S. FDA for difluprednate ophthalmic emulsion 0.05%, which is the generic version of Durezol® and ...
read more
Friday, November 19, 2021
Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to ...
read more
Wednesday, November 17, 2021
Endo International plc announced that its subsidiary, Par Sterile Products, LLC (Par Sterile), has entered into a cooperative agreement to expand its sterile fill-finish manufacturing production ...
read more
Wednesday, November 17, 2021
Twist Bioscience Corporation has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody, discovered and optimized by ...
read more
Tuesday, November 16, 2021
Health Canada has authorized the use of the Moderna Spikevax COVID-19 vaccine as a booster shot. A COVID-19 booster shot is an extra dose of the vaccine given after completion of the primary vaccine ...
read more
Monday, November 15, 2021
Regeneron Pharmaceuticals announced that the European Commission (EC) has approved the casirivimab and imdevimab antibody cocktail, known as REGEN-COV® in the U.S. and Ronapreve™ in the European Union...
read more
Wednesday, November 03, 2021
AbCellera announced an additional purchase by the U.S. government from Eli Lilly and Company (Lilly) for bamlanivimab with etesevimab for administration together. This neutralizing antibody therapy is...
read more
Monday, November 01, 2021
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the completion of its rolling submission to ...
read more
Monday, November 01, 2021
Novavax, a biotech company dedicated to developing and commercializing next-gen vaccines, and Serum Institute of India, the world's highest volume vaccine manufacturer, announced that the National ...
read more
Monday, November 01, 2021
Pfizer and BioNTech announced that the FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of
read more
Pfizer and BioNTech announced that the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17 to 0, with 1 abstention, to recommend that the FDA grant Emergency Use ...
read more